首页> 外国专利> Method of prevention of capsular opacification and fibrosis after cataract extraction and/or prevention of fibrosis around a shunt or stent after glaucoma surgery

Method of prevention of capsular opacification and fibrosis after cataract extraction and/or prevention of fibrosis around a shunt or stent after glaucoma surgery

机译:青光眼手术后预防白内障摘除后囊混浊和纤维化和/或预防分流管或支架周围纤维化的方法

摘要

A method of preventing capsular opacification and fibrosis after cataract extraction and and/or preventing fibrosis around a shunt or stent after glaucoma surgery is disclosed herein. In the cataract procedure, after the cortex and nucleus of the natural lens with the cataract has been removed, a photosensitizer is applied inside the lens capsule, a posterior portion of the lens capsule is irradiated so as to activate cross-linkers and prevent capsular opacification and fibrosis, and an intraocular lens is inserted into the lens capsule. In the glaucoma procedure, a fluid drainage opening is formed and/or a stent is inserted into the eye, a photosensitizer is applied inside an anterior chamber of the eye so that a diffused stream of the photosensitizer travels through the fluid drainage opening or the stent, and the tissue surrounding the fluid drainage opening or the stent is irradiated so as to activate cross-linkers and prevent fibrosis.
机译:本文公开了一种在白内障摘除后预防包膜混浊和纤维化和/或在青光眼手术后预防分流器或支架周围的纤维化的方法。在白内障手术中,将具有白内障的天然晶状体的皮层和核去除后,在晶状体囊内部应用光敏剂,对晶状体囊的后部进行照射,以激活交联剂并防止荚膜混浊纤维化,将人工晶状体插入晶状体囊。在青光眼手术中,形成排液口和/或将支架插入眼睛,在眼睛的前房内部应用光敏剂,使光敏剂的扩散流穿过排液口或支架然后照射排液口或支架周围的组织,以激活交联剂并防止纤维化。

著录项

  • 公开/公告号US10195081B1

    专利类型

  • 公开/公告日2019-02-05

    原文格式PDF

  • 申请/专利权人 GHOLAM A. PEYMAN;

    申请/专利号US201715631219

  • 发明设计人 GHOLAM A. PEYMAN;

    申请日2017-06-23

  • 分类号A61F2/14;A61F9/007;A61F9;A61N5/06;A61M27;A61B17/28;A61B34;A61F2;

  • 国家 US

  • 入库时间 2022-08-21 12:09:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号